Responses
Regular and Young Investigator Award Abstracts
Combination Immunotherapies
860 CD40 agonism is required to promote the function of cross-presenting dendritic cells and increase triple negative breast cancer response to radiation and CTLA4 inhibition
Compose a Response to This Article
Other responses
No responses have been published for this article.
